Pharmafile Logo

Gavi

- PMLiVE

Trial combining British and Russian COVID-19 vaccines could begin in February

AstraZeneca announced the clinical trial programme in December

- PMLiVE

Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions

Possible adverse events reported at a vaccination centre in the US

EU flag

EU proposes vaccine-sharing mechanism with low-income countries

Mechanism could provide low-income countries with early access to COVID-19 vaccines

- PMLiVE

WHO’s director-general deems vaccine nationalism a “catastrophic moral failure”

Tedros Adhanom Ghebreyesus warns bilateral deals could threaten COVAX facility

- PMLiVE

NHS is set to begin offering COVID-19 vaccinations to over-70s this week

Announcement comes as ten new vaccination centres open in England

- PMLiVE

Cambridge University develops DNA test for secondary infections in COVID-19 patients

Test can identify cases of ‘ventilator-associated pneumonia’

- PMLiVE

Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU

'Temporary' reduction comes as companies bolster production capacity for the year

- PMLiVE

The search for effective drug treatments for COVID-19

PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences

- PMLiVE

PHE study finds people who have had COVID-19 can still transmit the virus

Protection after infection lasts for at least five months on average

- PMLiVE

UK pharmacies to begin administering COVID-19 vaccinations

Pharmacies will join the effort to bolster the UK’s mass vaccination rollout

- PMLiVE

Celltrion’s investigational mAb cuts COVID-19 recovery time

Patients treated with mAb recovered 3.4 to 6.4 days quicker compared to placebo

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links